invest in the future of point-of-use testing
For investors, portfolio companies, funding foundations, strategic partners, philanthropic organizations, or companies interested in backing the development and launch of specific biomarker tests.
Your objective may be financial return, market participation, strategic access, health innovation, or the creation of new diagnostics for lasting social impact.
Returns tied to tests people can actually use
-
Bio-Stream is not only developing individual diagnostic products. It is building a platform that can support many biomarker tests through shared infrastructure.
-
That creates a different kind of opportunity: funding specific tests that can move through a repeatable platform and reach users through commercialization, distribution, and deployment pathways.
-
We leverage a multi-billion-dollar spend from university-based biosensor development.
-
Our novel business model drives an organic network effect.
Investing in a test makes sense when...
-
a biomarker you believe has strong market potential
-
a test category is connected to a current product or service you care about
-
a test for your existing portfolio company could help sell more of its existing product (ex. supplements)
-
a condition, pathogen, or health decision you want to support can help the people you know
-
a strong return-on-investment (royalty) is driven by scalable consumable test sales
Instead of funding a single, isolated product with its own standalone device, software, and commercial pathway, investors can participate in a broader ecosystem designed to support many tests through one platform.
Investors own a royalty right allowing them to participate in the revenue of each consumable test cartridge sold globally. This is part of the trax™ platform business model.
Interested in earning from the sale of a specific test consumable?
Bio-Stream can:
-
Showcase specific biomarker test opportunities
-
Outline how a test could generate return through consumable sales (ie. market potential)
-
Identify tests aligned with market demand, health need, or strategic interest
-
Validate every test before investment dollars are required (ie. ensuring reduced "technology risk" for all investors)
-
Your tests' participation in a platform designed to support many diagnostic tests over time
-
Enable the assignment of your royalty payments to others (ie. estate planning)
-
Help bring a strong return-on-investment coupled with meaningful social impact